Li, W., Kang, Z., Li, S., Zhao, M., Li, Y., Yin, W., Ke, X. (2026). A phase I study to assess the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of KH617 for patients with advanced solid tumors (including diffuse gliomas of adulthood).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2046